Speciality: Oncology
Description:
Welcome to our special feature on relapsed B-cell Acute Lymphoblastic Leukemia (B-cell ALL) in adults. Join leading experts Dr. Riyaz Ahmad, Dr. Nitin Gupta, and Dr. Eesha Kaul as they explore the latest breakthroughs in treating this aggressive form of leukemia. With years of experience in hematology and oncology, they bring valuable insights into how modern medicine is reshaping the outlook for adult patients.
In this video, our experts discuss the challenges of relapsed B-cell ALL and how innovative treatments like CAR T-cell therapy, blinatumomab, and inotuzumab ozogamicin are offering new hope. They highlight the importance of precision medicine, the evolving role of stem cell transplantation, and the need for holistic care in improving outcomes and quality of life for patients.
Thank you for watching. We hope this video offers clarity and encouragement to patients, families, and healthcare professionals. Don’t forget to like, share, and follow our channel for more updates on cutting-edge treatments and expert perspectives in cancer care.
See More Webinars @ Hidoc Webinars
1.
Doctors say lung cancer is still the deadliest cancer, but hope is growing
2.
Child Death Rates Are Rising in the U. s. ; Water Beads Warning; Cancer Studies Retracted.
3.
FDA Leaders Explain Their Choice Regarding Cancer Risk Warning in CAR-T Investigation.
4.
The FDA has approved momelotinib for use in myelofibrosis patients who also have anemia.
5.
Virtual Reality Travel Reduces Cancer Pain.
1.
Clinical Decision-Making in Oligometastatic Cancer: A Case-Based Perspective
2.
Iron Homeostasis Throughout the Female Lifespan
3.
The Benefits and Side Effects of Vidaza Syndrome
4.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
5.
Exercise Rehabilitation in Hematologic Disease Survivorship
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
3.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
4.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
5.
Preventing Blood Clots: The Importance of Venous Thromboembolism Management
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation